Clinical trial
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women…
NCT00066703 · ETOP IBCSG Partners Foundation, Other · Completed
Key facts
| NCT number | NCT00066703 |
|---|---|
| Title | Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer |
| Official title | A Phase III Trial Evaluating The Role Of Exemestane Plus GnRH Analogue As Adjuvant Therapy For Premenopausal Women With Endocrine Responsive Breast Cancer |
| Acronym | TEXT |
| Lead sponsor | ETOP IBCSG Partners Foundation, Other |
| Collaborators | National Cancer Institute (NCI) NIH Breast International Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | exemestane, tamoxifen, triptorelin |
| Enrollment | 2,672 |
| Start date | Nov 3, 2003 |
| Primary completion | Mar 11, 2011 |
| Completion | Oct 23, 2024 |
| First posted | Aug 7, 2003 |
| Last update posted | Feb 6, 2026 |
| Countries | Australia, Belgium, Brazil, Canada, Egypt, Germany, Hungary, India, Italy, New Zealand, Peru, Slovenia and 5 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: